To further investigate GRPEL2 mRNA and protein expression in gliomas, we performed quantitative an RT-PCR and Western blotting of healthy brain tissue in contrast to the U87, LN229, GBM8401, U118MG, and LNZ308 glioma cell lines. The gene discussed is GRPEL2; the disease is central nervous system cancer.